These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15240620)

  • 1. Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations.
    Ebeling T; Vierimaa O; Kytölä S; Leisti J; Salmela PI
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3392-6. PubMed ID: 15240620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
    Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
    Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
    Jap TS; Chiu CY; Won JG; Wu YC; Chen HS
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):336-42. PubMed ID: 15730416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.
    Tham E; Grandell U; Lindgren E; Toss G; Skogseid B; Nordenskjöld M
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3389-95. PubMed ID: 17623761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.
    Owens M; Ellard S; Vaidya B
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):350-4. PubMed ID: 17854391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
    Agarwal SK; Debelenko LV; Kester MB; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Heppner C; Crabtree JS; Lubensky IA; Zhuang Z; Kim YS; Chandrasekharappa SC; Collins FS; Liotta LA; Spiegel AM; Burns AL; Emmert-Buck MR; Marx SJ
    Hum Mutat; 1998; 12(2):75-82. PubMed ID: 9671267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
    Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
    Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
    Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis in a Chinese family with multiple endocrine neoplasia type 1.
    Zha BB; Liang W; Liu J; Cheng J; Hong XW; Liu J; Li YM; Ma D
    Chin Med J (Engl); 2010 Mar; 123(5):569-73. PubMed ID: 20367983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
    Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
    Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple endocrine neoplasia type 1 variants and phenocopies].
    Mamedova EO; Mokrysheva NG; Przhiialkovskaia EG; Pigarova EA; Rozhinskaia LIa; Tiul'pakov AN
    Ter Arkh; 2014; 86(10):87-91. PubMed ID: 25509899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1).
    Karges W; Schaaf L; Dralle H; Boehm BO
    Exp Clin Endocrinol Diabetes; 2000; 108(5):334-40. PubMed ID: 10989951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1.
    Toledo RA; Lourenço DM; Coutinho FL; Quedas E; Mackowiack I; Machado MC; Montenegro F; Cunha-Neto MB; Liberman B; Pereira MA; Correa PH; Toledo SP
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):377-84. PubMed ID: 17555499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
    Ellard S; Hattersley AT; Brewer CM; Vaidya B
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):169-75. PubMed ID: 15670192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
    Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.